Nandagopal Vrindavanam, M.D.
Hematology & Oncology Physician · Bradenton, FL
Nandagopal Vrindavanam, M.D. is a hematology & oncology physician with a practice address in Bradenton, Florida, and NPI 1912994971, issued on Oct 4, 2005. Check the license on the Florida health license search; the Medicare figures below come from public CMS files.
- Name
- Nandagopal Vrindavanam
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- Practice location
- 6555 Cortez RD W, Bradenton, FL 34210
- Phone
- (727) 344-6569
- Enumerated
- Oct 4, 2005
- Entity
- Type 1 · individual
Verify Nandagopal Vrindavanam in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersFlorida health license searchCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
47% more Medicare Part D claims than the average hematology & oncology physician in 2024
1,299 Medicare Part D claims for 205 beneficiaries, against an average of 885 among the 8,428 providers of this specialty who prescribed in Part D. Brand-name drugs were 22% of claims. 133 claims were for opioids.
Most prescribed
- Dexamethasone85 claims
- Potassium Chloride71 claims
- Anastrozole70 claims
- Hydroxyurea65 claims
- Oxycodone Hcl61 claims
- Prednisone60 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
One hospital or facility affiliation
- Multicare Health SystemTacoma, WA
Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.
Hematology & Oncology Physician providers in Florida
There are 703 hematology & oncology physician records in Florida.
Other hematology & oncology physician records in Florida
- Nayef Abdel-Razeq, MDJacksonville, FL1750900916
- Ahmed Abdelhakeem, MDJacksonville, FL1023690104
- Anna Abraham, MDPembroke Pines, FL1922093335
- Yousif Abubakr, MDJacksonville, FL1023013497
- Ziad Abuhelwa, MDTampa, FL1972113298
- John Accomando, M.D.Tampa, FL1649380361
- Peter Acs, M.D.Ocala, FL1861445421
- Pooja Advani, MDJacksonville, FL1386876928
- Dimitrios Agaliotis, MDFernandina Beach, FL1790764272
- Manmeet Ahluwalia, MDMiami, FL1760623557
Common questions
What is Nandagopal Vrindavanam, M.D.'s NPI number?
Nandagopal Vrindavanam, M.D.'s National Provider Identifier (NPI) is 1912994971, issued on Oct 4, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Nandagopal Vrindavanam, M.D. located?
The NPPES record lists a practice address at 6555 Cortez RD W, Bradenton, FL, 34210. Phone: (727) 344-6569. Providers update this record themselves, so call before visiting.
How can I verify Nandagopal Vrindavanam, M.D.'s license?
Search the Florida health license search at https://mqa-internet.doh.state.fl.us/mqasearchservices/healthcareproviders. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Nandagopal Vrindavanam, M.D. prescribe under Medicare Part D?
In 2024, Nandagopal Vrindavanam, M.D. had 1,299 Medicare Part D claims for 205 beneficiaries; the average among hematology & oncology physician prescribers was 885. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.